The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 301–400 of 997
Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Abdul‐Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Suwaidi, J. M. S. A. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666171010115119 · Cited by 79
Self-citationHøjlund, K., Birk, J. B., Klein, D. K., Levin, K., Rose, A. J., Hansen, B. F., Nielsen, J. N., Beck‐Nielsen, H., & Wojtaszewski, J. F. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0897 · Cited by 77
Regulation of adiponectin secretion by insulin and amino acids in 3T3-L1 adipocytes
Blümer, R. M. E., van Roomen, C. P. A. A., Meijer, A. J., Houben-Weerts, J. H. P. M., Sauerwein, H. P., & Dubbelhuis, P. F. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.020 · Cited by 79
Fülöp, T., Larbi, A., & Douziech, N. (2003) · Pathologie Biologie · doi:10.1016/j.patbio.2003.09.007 · Cited by 77
Bonora, E., Capaldo, B., Perin, P. C., Prato, S. D., Mattia, G. D., Frittitta, L., Frontoni, S., Leonetti, F., Luzi, L., Marchesini, G., et al. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.05.002 · Cited by 76
Demozay, D., Rocchi, S., Mas, J.-C., Grillo, S., Pirola, L., Chavey, C., & OBBERGHEN, E. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312062200 · Cited by 79
Hong, S., Song, W., Zushin, P. H., Liu, B., Jedrychowski, M. P., Mina, A. I., Deng, Z., Čabarkapa, D., Hall, J. A., Palmer, C. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.012 · Cited by 77
One Bout of Exercise Alters Free-Living Postprandial Glycemia in Type 2 Diabetes
Oberlin, D. J., Mikus, C. R., Kearney, M. L., Hinton, P. S., Manrique, C. M., Leidy, H. J., Kanaley, J. A., Rector, R. S., & Thyfault, J. P. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182a54d85 · Cited by 78
Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations
Huang-Doran, I., Tomlinson, P., Payne, F., Gast, A., Sleigh, A., Bottomley, W., Harris, J., Daly, A., Rocha, N., Rudge, S. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.88766 · Cited by 69
Ruddock, M. W., Stein, A., Landaker, E., Park, J., Cooksey, R. C., McClain, D., & Patti, M.-E. (2008) · Journal of Biochemistry · doi:10.1093/jb/mvn105 · Cited by 75
Self-citationDevelopment of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells
Kumar, N., & Dey, C. S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01509-5 · Cited by 75
Maddux, B. A., Chan, A., Mandarino, L. J., Goldfine, I. D., & Filippis, E. A. D. (2006) · Diabetes Care · doi:10.2337/dc05-1367 · Cited by 75
Self-citationPhysiological and Molecular Determinants of Insulin Action in the Baboon
Chávez, A. O., López-Alvarenga, J. C., Tejero, M. E., Triplitt, C. L., Bastarrachea, R. A., Sriwijitkamol, A., Tantiwong, P., Voruganti, V. S., Musi, N., Comuzzie, A. G., et al. (2008) · Diabetes · doi:10.2337/db07-0790 · Cited by 73
Self-citationHan, X., Møller, L. L. V., Groote, E. D., Bojsen-Møller, K. N., Davey, J. R., Henríquez‐Olguín, C., Li, Z., Knudsen, J. R., Jensen, T. E., Madsbad, S., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12474 · Cited by 75
Karimi, A., Tutunchi, H., Naeini, F., Vajdi, M., Mobasseri, M., & Najafipour, F. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13698 · Cited by 74
Catalán, V., Gómez‐Ambrosi, J., Rotellar, F., Silva, C., Gil, M. J. C., Rodrı́guez, A., Cienfuegos, J. A., Salvador, J., & Frühbeck, G. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02777.x · Cited by 74
Fu, Z., Wu, J., Nesil, T., Li, M. D., Aylor, K. W., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00297.2016 · Cited by 74
Caturano, A., Galiero, R., Pafundi, P. C., Cesaro, A., Vetrano, E., Palmiero, G., Rinaldi, L., Salvatore, T., Marfella, R., Sardu, C., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108959 · Cited by 73
Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon
Park, J., Lertdumrongluk, P., Molnar, M. Z., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0286-3 · Cited by 73
Sourij, H., Zweiker, R., & Wascher, T. C. (2006) · Diabetes Care · doi:10.2337/dc05-2226 · Cited by 73
Therapeutic modification of arterial stiffness: An update and comprehensive review
Wu, C.-F. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i11.742 · Cited by 74
Monti, L., Setola, E., Fragasso, G., Camisasca, R., Lucotti, P., Galluccio, E., Origgi, A., Margonato, A., & Piatti, P. (2006) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00083.2005 · Cited by 84
Campia, U., Tesauro, M., Daniele, N. D., & Cardillo, C. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.028 · Cited by 72
Staels, B. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x36440 · Cited by 72
Zierath, J. R., & Wallberg‐Henriksson, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04270.x · Cited by 71
Insulin resistance metabolic stress and atherosclerosis
Wang, H. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s308 · Cited by 75
Global IRS-1 phosphorylation analysis in insulin resistance
Langlais, P. R., Yi, Z., Finlayson, J., Luo, M., Mapes, R., Filippis, E. D., Meyer, C., Plummer, E., Tongchinsub, P., Mattern, M., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2271-9 · Cited by 76
Self-citationNovel agents for the treatment of type 2 diabetes
DeFronzo, R. A., Triplitt, C. L., Abdul-Ghani, M., & Cersosimo, E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.2.100 · Cited by 83
Self-citationInsulin Resistance, Obesity, and Lipotoxicity
Yazıcı, D., Demir, S. Ç., & Sezer, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_14 · Cited by 85
Giani, J. F., Muñoz, M. C., Mayer, M. A., Veiras, L. C., Arranz, C. T., Taira, C. A., Turyn, D., Toblli, J. E., & Dominici, F. P. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00803.2009 · Cited by 70
Højlund, K., Yi, Z., Lefort, N., Langlais, P. R., Bowen, B. P., Levin, K., Beck‐Nielsen, H., & Mandarino, L. J. (2009) · Diabetologia · doi:10.1007/s00125-009-1624-0 · Cited by 66
Self-citationSelective Insulin Resistance in the Kidney
Horita, S., Nakamura, M., Suzuki, M., Satoh, N., Suzuki, A., & Seki, G. (2016) · BioMed Research International · doi:10.1155/2016/5825170 · Cited by 71
High Fat Diet Regulation of β-Cell Proliferation and β-Cell Mass
GANNON, M. A. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010066 · Cited by 77
Merry, T. L., Tran, M., Stathopoulos, M., Wiede, F., Fam, B. C., Dodd, G. T., Clarke, I. J., Watt, M. J., Andrikopoulos, S., & Tiganis, T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5428 · Cited by 69
Figueira, F. R., Umpierre, D., Casali, K. R., Tetelbom, P. S., Henn, N. T., Ribeiro, J. P., & Schaan, B. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057733 · Cited by 68
The impact of insulin resistance on endothelial function, progenitor cells and repair
Cubbon, R. M., Rajwani, A., & Wheatcroft, S. B. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.027 · Cited by 69
Rapamycin partially prevents insulin resistance induced by chronic insulin treatment
Berg, C. E., Lavan, B. E., & Rondinone, C. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00333-9 · Cited by 69
Sabe, S. A., Feng, J., Sellke, F. W., & Abid, M. R. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00603.2021 · Cited by 67
A review on critical appraisal and pathogenesis of polycystic ovarian syndrome
Hajam, Y. A., Rather, H., Neelam, N., Kumar, R., Basheer, M., & Reshi, M. S. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100162 · Cited by 86
NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness
Wu, X., & Williams, K. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.244525 · Cited by 67
Jonas, M., Edelman, E. R., Groothuis, A., Baker, A. B., Seifert, P. A., & Rogers, C. (2005) · Circulation Research · doi:10.1161/01.res.0000183730.52908.c6 · Cited by 67
Rajasekar, N., Nath, C., Hanif, K., & Shukla, R. (2017) · Life Science · doi:10.1016/j.lfs.2016.09.020 · Cited by 65
Sartipy, P., & Loskutoff, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306922200 · Cited by 67
Meyer, M., Levin, K., Grimmsmann, T., Beck‐Nielsen, H., & Klein, H. H. (2002) · Diabetologia · doi:10.1007/s00125-002-0830-9 · Cited by 68
Emerging Concepts in the Pathophysiology of Type 2 Diabetes Mellitus
Surampudi, P. N., John‐Kalarickal, J., & Fonseca, V. A. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20113 · Cited by 68
Regulation of GLUT4 gene expression by SREBP-1c in adipocytes
Im, S., Kwon, S., Kang, S.-Y., Kim, T. H., Kim, H., Hur, M., Kim, K., & Ahn, Y. (2006) · Biochemical Journal · doi:10.1042/bj20060696 · Cited by 69
Dong, F., Fang, C. X., Yang, X., Zhang, X., Lopez, F. L., & Ren, J. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0230-7 · Cited by 67
Prevalence of diabetes and obesity in association with prematurity and growth restriction
Kopec, G. L., Shekhawat, P., & Mhanna, M. J. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s115890 · Cited by 66
Diet‐induced obesity alters anabolic signalling in mice at the onset of skeletal muscle regeneration
Brown, L. A., Lee, D. E., Patton, J. F., Perry, R. A., Brown, J. L., Baum, J., Smith‐Blair, N., Greene, N. P., & Washington, T. A. (2015) · Acta Physiologica · doi:10.1111/apha.12537 · Cited by 71
Mechanisms of Vascular Complications in Prediabetes
Milman, S., & Crandall, J. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.004 · Cited by 68
Insulin Signalling and Resistance in Patients with Chronic Heart Failure
Kemppainen, J., Tsuchida, H., Stolen, K. Q., Karlsson, H., Björnholm, M., Heinonen, O. J., Nuutila, P., Krook, A., Knuuti, J. M., & Zierath, J. R. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042648 · Cited by 65
Zecchin, H. G., Bezerra, R. M. N., Carvalheira, J. B. C., Carvalho-Filho, M. A., Metze, K., Franchini, K. G., & Saad, M. J. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1073-0 · Cited by 65
The metabolic syndrome and endothelial dysfunction: Common highway to type 2 diabetes and CVD?
Diamant, M., & Tushuizen, M. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0061-4 · Cited by 64
Houben, A. J. H. M., Eringa, E. C., Jonk, A. M., Serné, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2011) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-011-0214-0 · Cited by 62
Caruso, M. A., Ma, D., Msallaty, Z., Lewis, M. K., Seyoum, B., Al-Janabi, W., Diamond, M. P., Abou‐Samra, A., Højlund, K., Tagett, R., et al. (2014) · Diabetes · doi:10.2337/db13-1872 · Cited by 65
Yi, Z., Langlais, P. R., Filippis, E. A. D., Luo, M., Flynn, C. R., Schroeder, S., Weintraub, S. T., Mapes, R., & Mandarino, L. J. (2007) · Diabetes · doi:10.2337/db06-1355 · Cited by 65
Self-citationResistin is regulated by C/EBPs, PPARs, and signal-transducing molecules
Song, H., Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02551-2 · Cited by 64
The effects of thiazolidinediones on blood pressure levels – A systematic review
Sarafidis, P. A., & Nilsson, P. M. (2006) · Blood Pressure · doi:10.1080/08037050600853720 · Cited by 64
Luo, M., Langlais, P. R., Yi, Z., Lefort, N., Filippis, E. A. D., Hwang, H., Christ-Roberts, C. Y., & Mandarino, L. J. (2007) · Endocrinology · doi:10.1210/en.2007-0049 · Cited by 63
Self-citationWang, Y., & Yao, M. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.09.002 · Cited by 62
Wheatcroft, S. B., Shah, A. M., Li, J., Duncan, E. R., Noronha, B., Crossey, P. A., & Kearney, M. T. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2645 · Cited by 63
Whole food approach for type 2 diabetes prevention
Xi, P., & Liu, R. H. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500963 · Cited by 63
Abdelmageed, M. E., Shehatou, G. S. G., Abdelsalam, R. A., Suddek, G. M., & Salem, H. A. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1583-4 · Cited by 64
Hager, L., Li, L., Pun, H., Liu, L., Hossain, M. A., Maguire, G. F., Naples, M., Baker, C., Magomedova, L., Tam, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340919 · Cited by 63
Gene and MicroRNA Expression Responses to Exercise; Relationship with Insulin Sensitivity
McLean, C. G., Mielke, C. J., Cordova, J. M., Langlais, P. R., Bowen, B. P., Miranda, D. N., Coletta, D. K., & Mandarino, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127089 · Cited by 60
Self-citationMadi, H. A., Riches‐Suman, K., Warburton, P., O'Regan, D. J., Turner, N. A., & Porter, K. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00608.2008 · Cited by 60
Inflammatory Cytokines and the Risk of Cardiovascular Complications in Type 2 Diabetes
Mahmoud, F. F., & Al‐Ozairi, E. (2013) · Disease Markers · doi:10.1155/2013/931915 · Cited by 61
Insulin Resistance in Striated Muscle-specific Integrin Receptor β1-deficient Mice
Zong, H., Bastie, C. C., Xu, J., Fässler, R., Campbell, K. P., Kurland, I. J., & Pessin, J. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807408200 · Cited by 63
Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension
Zhou, M.-S., Schulman, I. H., & Raij, L. R. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2008 · Cited by 60
Batumalaie, K., Amin, M. A., Murugan, D. D., Sattar, M. Z. A., & Abdullah, N. A. (2016) · Scientific Reports · doi:10.1038/srep27236 · Cited by 60
Contribution of salt intake to insulin resistance associated with hypertension
Ogihara, T., Asano, T., & Fujita, T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00315-1 · Cited by 60
Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A. E.-N., Youssef, M., Tawfik, S. H., & Domínguez, H. (2015) · Endocrine · doi:10.1007/s12020-015-0709-4 · Cited by 61
Liang, H., Tantiwong, P., Sriwijitkamol, A., Shanmugasundaram, K., Mohan, S., Espinoza, S. E., DeFronzo, R. A., Dubé, J. J., & Musi, N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247510 · Cited by 59
Self-citationMetabolic syndrome in women with polycystic ovary syndrome
Chandrasekaran, S., & Sagili, H. (2018) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12519 · Cited by 61
Leng, Y., Steiler, T. L., & Zierath, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1436 · Cited by 58
Atherosclerosis in diabetes and insulin resistance
Reusch, J. E. B., & Draznin, B. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00620.x · Cited by 58
Luo, M., Reyna, S. M., Wang, L., Yi, Z.-P., Carroll, C. A., Dong, L., Langlais, P. R., Weintraub, S. T., & Mandarino, L. J. (2005) · Endocrinology · doi:10.1210/en.2005-0260 · Cited by 59
Self-citationUremic Cardiomyopathy and Insulin Resistance
Semple, D. J., Smith, K., Bhandari, S., & Seymour, A. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090900 · Cited by 58
Nadeau, K. J., Ehlers, L. B., Aguirre, L. E., Moore, R. L., Jew, K. N., Ortmeyer, H. K., Hansen, B. C., Reusch, J. E. B., & Draznin, B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00543.2005 · Cited by 57
Frederiksen, C. M., Højlund, K., Hansen, L., Oakeley, E. J., Hemmings, B., Abdallah, B. M., Brusgaard, K., Beck-Nielsen, H., & Gaster, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1122-9 · Cited by 57
Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?
Georgescu, E. F. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0110-2 · Cited by 59
Muscular response and adaptation to diabetes mellitus
Sun, Z. (2008) · Frontiers in bioscience · doi:10.2741/3038 · Cited by 56
Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Turco, S. D., Gaggini, M., Daniele, G., Basta, G., Folli, F. B., Sicari, R., & Gastaldelli, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130010 · Cited by 58
Lew, K. S., Pearson, J. T., Schwenke, D. O., & Katare, R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0484-4 · Cited by 57
Fang, C. X., Dong, F., Ren, B. H., Epstein, P. N., & Ren, J. T. (2005) · Diabetologia · doi:10.1007/s00125-005-1940-y · Cited by 56
Nyman, E., Rajan, M. R., Fagerholm, S., Brännmark, C., Cedersund, G., & Strålfors, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608927 · Cited by 56
Christ-Roberts, C. Y., Pratipanawatr, T., Pratipanawatr, W., Berria, R., Belfort, R., & Mandarino, L. J. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00605.2003 · Cited by 55
Self-citationProgress and Controversies: Treating Obesity and Insulin Resistance in the Context of Hypertension
McGill, J. B., Haffner, S. M., Rees, T., Sowers, J. R., Tershakovec, A. M., & Weber, M. A. (2009) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.00065.x · Cited by 54
Insulin Signaling Defects in Type 2 Diabetes
Leng, Y., Karlsson, H., & Zierath, J. R. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000021432.84588.f6 · Cited by 54
Functional food and diabetes: a natural way in diabetes prevention?
Ballali, S., & Lanciai, F. (2011) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2011.637487 · Cited by 58
The good and the bad in the link between insulin resistance and vascular calcification
Fadini, G. P., Pauletto, P., Avogaro, A., & Rattazzi, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.015 · Cited by 55
Han, L., Yu, Y., Sun, X., & Wang, B. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.04.001 · Cited by 55
Wang, C. C. L., Sorribas, V., Sharma, G. D., Levi, M., & Draznin, B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.032 · Cited by 54
Targeting glycogen synthase kinase-3 in insulin signalling
Frame, S., & Zheleva, D. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.429 · Cited by 55
Endothelial Dysfunction and Its Role in Diabetic Vascular Disease
Hartge, M., Kintscher, U., & Unger, T. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.06.006 · Cited by 54
Mielke, C., Lefort, N., McLean, C. G., Cordova, J. M., Langlais, P. R., Bordner, A. J., Te, J. A., Ozkan, S. B., Willis, W. T., & Mandarino, L. J. (2014) · Biochemistry · doi:10.1021/bi401651e · Cited by 53
Self-citationMetabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Kalra, S., Unnikrishnan, A., Baruah, M. P., Sahay, R. K., & Bantwal, G. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s286888 · Cited by 55
Luo, Z., Fu, C., Li, T., Gao, Q., Miao, D., Xu, J., & Zhao, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07630 · Cited by 52
Exercise and Insulin Resistance
Whillier, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_9 · Cited by 57
Zhao, H.-L., Wu, H., Duan, M., Liu, R., Quanhong, Z., Zhang, K., & Wang, L. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s288011 · Cited by 51
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
